News
According to @WHO, #OmicronVariant Has a Substantial Growth Advantage over Delta ... - Latest Tweet by PIB India
The latest Tweet by PIB India states, 'According to @WHO, #OmicronVariant has a substantial growth advantage over Delta variant. Clinical severity data from South Africa, UK, Canada, and Denmark suggests a reduced risk of hospitalization for #Omicron compared to Delta - @MoHFW_INDIA'
According to @WHO, #OmicronVariant has a substantial growth advantage over Delta variant.
Clinical severity data from South Africa, UK, Canada, and Denmark suggests a reduced risk of hospitalization for #Omicron compared to Delta
- @MoHFW_INDIA pic.twitter.com/nJBjnWhx3y— PIB India (@PIB_India) January 12, 2022
(The above story first appeared on LatestLY on Jan 12, 2022 04:37 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
